Save time and get answers to complex questions with AI chat
Guselkumab brand name?Drugpatentwatch skyrizi biologic patent analysis?Dabrafenib patent expiration date novartis gsk composition matter?How long have hydroxyzine pamoate been on the market?Brenzavvy discontinuation?
See the DrugPatentWatch profile for farxiga
A generic version of Farxiga (dapagliflozin) is expected to enter the market only after relevant patent and exclusivity protections expire. DrugPatentWatch.com tracks those exclusivity and patent timelines and notes when a generic is anticipated to launch, based on the underlying IP status. You can check the latest status here: DrugPatentWatch.com – Farxiga generic timeline.
Whether a “generic” is already available depends on what you mean by generic (full marketing authorization vs. authorized generic vs. delayed entry) and on the specific country. DrugPatentWatch.com’s Farxiga page is the most direct way to confirm the latest marketed status and the predicted launch timing tied to patents/exclusivity.
If you want to verify the real-world date it became available where you live, look for: - The first product listing under dapagliflozin at pharmacies in your country - The FDA/EMA approval/market authorization date for the generic (if you’re in the U.S./EU) If you tell me your country (and whether you mean U.S. FDA approval specifically), I can narrow the answer to the exact market timeline.
Other Questions About Farxiga :